These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 1780043)
21. Amelioration of naloxone-precipitated opioid withdrawal symptoms by peripheral administration of the enkephalinase inhibitor acetorphan. Livingston SJ; Sewell RD; Rooney KF; Smith HJ Psychopharmacology (Berl); 1988; 94(4):540-4. PubMed ID: 3131801 [TBL] [Abstract][Full Text] [Related]
22. In vivo 'enkephalinase' inhibition by acetorphan in human plasma and CSF. Spillantini MG; Geppetti P; Fanciullacci M; Michelacci S; Lecomte JM; Sicuteri F Eur J Pharmacol; 1986 Jun; 125(1):147-50. PubMed ID: 3015640 [TBL] [Abstract][Full Text] [Related]
23. Effects of an enkephalinase inhibitor on esophageal motility in man. Chaussade S; Hamm R; Lecomte JM; Couturier D; Guerre J Gastroenterol Clin Biol; 1988 Nov; 12(11):793-6. PubMed ID: 3220232 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of apomorphine-induced yawning and penile erection by neurotensin. Nouel D; Costentin J Peptides; 1991; 12(4):755-9. PubMed ID: 1788138 [TBL] [Abstract][Full Text] [Related]
25. Effects of acetorphan, an enkephalinase inhibitor, on experimental and acute diarrhoea. Baumer P; Danquechin Dorval E; Bertrand J; Vetel JM; Schwartz JC; Lecomte JM Gut; 1992 Jun; 33(6):753-8. PubMed ID: 1624154 [TBL] [Abstract][Full Text] [Related]
26. A C-terminal cyclic 8-13 neurotensin fragment analog appears less exposed to neprilysin when it crosses the blood-brain barrier than the cerebrospinal fluid-brain barrier in mice. Van Kemmel FM; Dubuc I; Bourdel E; Fehrentz JA; Martinez J; Costentin J Neurosci Lett; 1996 Oct; 217(1):58-60. PubMed ID: 8905739 [TBL] [Abstract][Full Text] [Related]
27. Non-cholinergic neural excitation of the human rectum induced by acetorphan, an inhibitor of enkephalinase. Grimaud JC; Bouvier M; Naudy B; Salducci J Gastroenterol Clin Biol; 1989 Oct; 13(10):799-803. PubMed ID: 2591688 [TBL] [Abstract][Full Text] [Related]
31. [Acetorphan, a potent enkephalinase inhibitor, does not modify orocecal and colonic transit times in healthy subjects]. Baumer P; Akoué K; Bergmann JF; Chaussade S; Nepveux P; Alexandre CL; Schwartz JC; Lecomte JM Gastroenterol Clin Biol; 1989 Nov; 13(11):947-8. PubMed ID: 2612837 [No Abstract] [Full Text] [Related]
32. Naloxone-reversible inhibition of gall-bladder mucosal fluid secretion in experimental cholecystitis in the cat by acetorphan, an enkephalinase inhibitor. Jivegård L; Pollard H; Moreau J; Schwartz JC; Thune A; Svanvik J Clin Sci (Lond); 1989 Jul; 77(1):49-54. PubMed ID: 2758762 [TBL] [Abstract][Full Text] [Related]
33. Protection of atrial natriuretic factor against degradation: diuretic and natriuretic responses after in vivo inhibition of enkephalinase (EC 3.4.24.11) by acetorphan. Gros C; Souque A; Schwartz JC; Duchier J; Cournot A; Baumer P; Lecomte JM Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7580-4. PubMed ID: 2529543 [TBL] [Abstract][Full Text] [Related]
34. Antinociceptive and antidepressant-like profiles of BL-2401, a novel enkephalinase inhibitor, in mice and rats. Kita A; Imano K; Seto Y; Yakuo I; Deguchi T; Nakamura H Jpn J Pharmacol; 1997 Dec; 75(4):337-46. PubMed ID: 9469639 [TBL] [Abstract][Full Text] [Related]
35. [Action of acetorphan, an enkephalinase inhibitor, in acute diarrhea]. Baumer P; Danquechin Dorval E; Bertrand J; Vetel JM; Schwartz JC; Lecomte JM Ann Gastroenterol Hepatol (Paris); 1992; 28(6-7):279-85. PubMed ID: 1285638 [No Abstract] [Full Text] [Related]
36. [Treatment of acute chemically induced diarrhea by inhibition of enkephalinase. Results of a pilot study]. Dorval ED; Regimbeau C; Gamelin E; Picon L; Bérard H Gastroenterol Clin Biol; 1995 Jan; 19(1):27-30. PubMed ID: 7720986 [TBL] [Abstract][Full Text] [Related]
37. Thiorphan and analogs: lack of correlation between potency to inhibit "enkephalinase A" in vitro and analgesic potency in vivo. Mendelsohn LG; Johnson BG; Scott WL; Frederickson RC J Pharmacol Exp Ther; 1985 Aug; 234(2):386-90. PubMed ID: 3894620 [TBL] [Abstract][Full Text] [Related]
38. The enkephalinase inhibitor, acetorphan, in acute diarrhoea. A double-blind, controlled clinical trial versus loperamide. Roge J; Baumer P; Berard H; Schwartz JC; Lecomte JM Scand J Gastroenterol; 1993 Apr; 28(4):352-4. PubMed ID: 8488368 [TBL] [Abstract][Full Text] [Related]
39. Relationship between enkephalinase inhibition of thiorphan in vivo and its analgesic activity. Hachisu M; Takahashi H; Hiranuma T; Shibazaki Y; Murata S J Pharmacobiodyn; 1985 Sep; 8(9):701-10. PubMed ID: 3910797 [TBL] [Abstract][Full Text] [Related]
40. Action of enkephalinase (EC 3.4.24.11) inhibition on the pre- and post-prandial electromyographic patterns of colon in rats. Benouali S; Berard H; Roche M Neuropeptides; 1993 May; 24(5):299-305. PubMed ID: 8392143 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]